Cabio Biotech (wuhan) Co. Ltd. Class ASSE: 688089

Announcement on Changing Major Asset Restructuring Project and Audit Signatory Accountant for 2025

· Issued by Cabio Biotech (wuhan) Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Changing Major Asset Restructuring Project and Audit Signatory Accountant for 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment